1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient population and prevalence of vascular lesions
Patients with Definite HHT No (%) No. of patients 376 Mean age (SD) (yr) 53.0 (43.4) Sex Male 151 (40.1) Female 225 (59.8) Imaging CTA/MRA 140 (37.2) DSA 46 (12.2) MRI 365 (97.1) Curacao criteria Epistaxis 334 (88.8) Mucocutaneous telangiectasia 327 (87.0) Visceral AVMs 321 (85.4) Family history 324 (86.2) Mutation analysis ENG 61 (49.6) ACVRL1 48 (39.0) SMAD4 14 (11.4) Chest CT 311 (82.7) Pulmonary AVMs 176 (56.6) Abd/pelv CT 344 (91.5) Hepatic vascular malformations 185 (53.8) Other GI vascular malformations 8 (2.3) Neuroimaging findings Cerebral AVM 48 (12.8) DVA 45 (12.0) Cavernoma/focal hemosiderin deposition 13 (3.5) Capillary telangiectasia 9 (2.4) Cerebral aneurysm 8 (2.1)
Note:—Abd indicates abdominal; pelv, pelvic; GI, gastrointestinal.